Edition:
India

Panacea Biotec Ltd (PNCA.NS)

PNCA.NS on National Stock Exchange of India

126.65INR
16 Jan 2017
Change (% chg)

-- (--)
Prev Close
Rs126.65
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
69,139
52-wk High
Rs147.95
52-wk Low
Rs83.70

PNCA.NS

Chart for PNCA.NS

About

Panacea Biotec Limited is a health management company. The Company's principal business activity is the manufacture of allopathic pharmaceuticals preparations. The Company's segments include Vaccines, Formulations, Research and Development; Healthcare and Real estate activities. Its Vaccines, Formulations and Research &... (more)
No analyst recommendations are available for PNCA.NS.

Overall

Beta: 1.08
Market Cap(Mil.): Rs7,521.59
Shares Outstanding(Mil.): 61.25
Dividend: --
Yield (%): --

Financials

  PNCA.NS Industry Sector
P/E (TTM): -- 30.00 30.92
EPS (TTM): -- -- --
ROI: -- 15.39 14.82
ROE: -- 16.57 16.24

BRIEF-Panacea Biotec announces receipt of EIR from USFDA

* Panacea Biotec Ltd. announces receipt of establishment inspection report (EIR) from USFDA Source text: http://corporates.bseindia.com/xml-data/corpfiling/AttachLive/462A15FE_20FB_40A7_883F_3D22A0646DA7_104704.pdf Further company coverage:

21 Nov 2016

BRIEF-Panacea Biotec Sept qtr loss narrows

* Panacea Biotec Ltd - sept quarter net loss 118.4 million rupees versus loss 170 million rupees year ago

11 Nov 2016

Earnings vs. Estimates